Unknown

Dataset Information

Cost-effectiveness of pharmacist care for managing hypertension in Canada.


ABSTRACT:

Background

More than half of all heart disease and stroke are attributable to hypertension, which is associated with approximately 10% of direct medical costs globally. Clinical trial evidence has demonstrated that the benefits of pharmacist intervention, including education, consultation and/or prescribing, can help to reduce blood pressure; a recent Canadian trial found an 18.3 mmHg reduction in systolic blood pressure associated with pharmacist care and prescribing. The objective of this study was to evaluate the economic impact of such an intervention in a Canadian setting.

Methods

A Markov cost-effectiveness model was developed to extrapolate potential differences in long-term cardiovascular and renal disease outcomes, using Framingham risk equations and other published

SUBMITTER: Marra C 

PROVIDER: S-EPMC5415065 | biostudies-literature | 2017 May-Jun

REPOSITORIES: biostudies-literature